Ours Privacy

Name: Ours Privacy
Brand: Ours Privacy

AI Native

Ours Privacy is a HIPAA-oriented customer data platform and privacy platform that controls, redacts, hashes, and routes event data to enable server-side dispatch to mainstream marketing destinations while bundling consent management, tag management, session replay, and experimentation tooling.

Est 2020|Valuation $43M|12 Ref Customers

LinkedIn 1K|Website|FTEs 31|HQ Houston, TX

Published Oct 14, 2026

01Common complaints

- Company sizes or stages where this product is overkill or insufficient - Very small practices with minimal ad spend may be better served by simpler analytics approaches (or no tracking) due to governance overhead and potential cost. - Industries or use cases where competitors are more appropriate - Non-healthcare enterprises that primarily require global consent and privacy operations across many internal systems may be better served by enterprise CMP/privacy platforms with broader governance feature sets. - Technical requirements that this product cannot meet - If an organization requires independent verification that no PHI ever reaches non-compliant tools, additional third-party auditing, strict internal controls, or a self-hosted architecture may be necessary. - Budget constraints that make alternatives more appropriate - If a buyer cannot justify a sales-led platform, community discussions indicate some organizations revert to minimal tracking or lower-cost analytics tools and accept trade-offs. - Specific workflows or integrations where the product falls short - Mission-critical destinations with complex offline conversion stitching should be validated in a proof of concept; public documentation is insufficient to guarantee fit for all edge cases. - Red flags in the buying process - Lack of transparent public pricing and limited independent third-party reviews. - Current limitations acknowledged by the vendor - CMP script blocking depends on proper configuration and early CMP loading; incomplete coverage is possible if implemented incorrectly. - Session replay documentation warns that some surfaces (URLs, query strings, document titles, attributes) may be recorded in clear text; this creates operational risk if PHI is present in those elements. - Features on the roadmap (not yet available) - The vendor provides frequent platform updates in blog posts; a formal public product roadmap with dates was not extracted in this research pass. - Scale limitations - The vendor states processing volumes at scale; these volume claims were not independently verified in the sources captured here. - Security or compliance gaps - SOC 2 Type II is stated by the vendor, but an attestation report was not publicly accessible in the materials reviewed. ISO certifications and public penetration test disclosures were not found. - API limitations or integration constraints - A public OpenAPI schema is documented, but detailed limits (rate limits, PII/PHI handling in APIs, retention policies) were not assessed in this run and should be validated during technical due diligence.

Deal disqualifiers: what makes a poor fit

Organizations that only require basic website analytics and do not need multi-destination dispatch or ad optimization.
Buyers that require extensive, independently validated third-party reviews and analyst coverage; the vendor has limited public third-party review presence in the captured materials.
Organizations requiring on-prem hosting or explicit non-domestic data residency guarantees that were not documented publicly in the sources reviewed.

Why some customers left for competitors (churn reasons)

No credible, source-backed churn narratives specific to Ours were found in the accessible public sources.

02Why they buy

- Competitive advantages validated by customer feedback (not just vendor claims) - Independent validation is limited in public sources. Community mentions place the vendor in the category of Freshpaint alternatives and include anecdotal pricing observations. - Unique features and capabilities competitors lack (based on documentation) - The vendor's documentation indicates the platform bundles event control, CMP script blocking, session replay/heatmaps, and experimentation/personalization within a single platform marketed for healthcare use cases. - A public OpenAPI schema endpoint indicates developer-accessible integration surfaces for custom integrations. - Areas where competitors clearly have advantages (balanced assessment) - Freshpaint exhibits greater public market presence and has explicit public documentation of HIPAA-mode semantics. - Dedicated CMP/privacy vendors may provide deeper enterprise governance, DSAR automation, and multi-jurisdiction support.

Why customers chose this product over alternatives (observed causes, not vendor endorsements)

From vendor positioning and community hints, primary reasons cited include:
- A healthcare-focused compliance posture and willingness to sign a BAA.
- Ability to dispatch events server-side to mainstream analytics and advertising destinations after data minimization.
- Vendor-provided implementation claims and perceived cost advantage in community discussion (anecdotal).

03Field reports

Important limitation

G2: the vendor has a seller profile with no reviews available in the captured materials, which limits the ability to perform sentiment analysis via standard review platforms.
Gartner Peer Insights: product-specific reviews were not accessible in this research pass due to access restrictions.
TrustRadius: no accessible review page was located in the searches performed.

Vendor testimonials (marketing-provided)

The vendor site includes vendor-provided testimonials referencing healthcare customers. These provide context on claimed fit and use cases but are not independent evidence of performance or compliance.

Community / social mentions (independent but sparse)

Practitioner forum posts include anecdotal mentions; for example, a forum commenter described Ours Privacy as a newer alternative that "may be a bit more affordable than Freshpaint." These references are anecdotal and not systematically validated.

Direct quotes (what's available, with context)

Community anecdote: one forum post noted that Ours Privacy "may be a bit more affordable than FreshPaint." This is an unverified community observation.
Category-level forum discussion: community posts indicate that many smaller practices struggle to justify enterprise tools and sometimes limit tracking; buyers evaluate multiple alternatives and cost/complexity are common decision drivers.

Common criticisms and complaints

Ours-specific complaints were limited in public sources due to sparse review coverage.
Category-level complaints relevant to this vendor:
- Cost sensitivity: buyer discussions indicate pricing pressure in the category and that cost is a frequent concern.
- Complexity/governance: HIPAA-safe marketing requires careful governance of PHI taxonomy and destination policies; this is a common operational pain point.

Vendor-published outcomes (unverified)

The vendor states that some clients have observed reductions in CAC after restoring conversion signals. These statements do not include methodology, sample sizes, or independent validation in the materials captured here.

Third-party case studies

No independent, detailed case studies with transparent methodology and verifiable metrics were located in the retrieved sources.

Critical evaluation

Performance claims can be context-dependent and depend on baseline tracking maturity, consent rates, destination policies, and data governance quality.
Recommendation for procurement: request reference calls with similar organizations, a walkthrough of data-sharing reports and consent evidence exports, and documentation of how the vendor detects and prevents data leak paths (for example, script tags outside CMP reach).

04Best fit

Company sizes

- Likely fit: - Digital health and multi-location provider groups: small-to-large organizations across growth to enterprise tiers. - Mid-market to enterprise health systems with moderate-to-substantial paid media spend and compliance oversight. - Notes: - The research did not provide independent data to confidently define ARR ranges; buyers should map fit to ad spend and event volumes instead of relying on revenue bands.

Industries and verticals where adoption is strongest (with customer examples)

Healthcare providers and health services organizations (vendor-referenced customers include provider brands).
Health and wellness brands.

Roles and personas: decision makers AND end users

Decision makers:
- VP/Director of Marketing / Growth
- Compliance / Privacy officers
- Security / IT risk
- Data/Analytics leadership
End users:
- Growth marketers (paid social/search)
- Marketing operations and analytics practitioners

Pain points and challenges the product addresses

Reducing the risk of PHI leakage via web pixels and trackers while maintaining measurement for ad optimization.
Restoring conversion signals for optimization where direct third-party pixels are not viable.
Consolidating multiple marketing tools (consent, tag management, replay) within a single vendor relationship oriented toward healthcare compliance.

Qualification criteria: what makes a suitable fit

Organizations that rely on paid acquisition and require conversion measurement without direct third-party pixel deployment.
Organizations that can commit to ongoing governance (event schemas, allowed fields, consent coverage).
Organizations that require a vendor willing to sign a BAA and to support healthcare compliance workflows.

05The pitch

What the product does (core value proposition in objective terms)

- Ours Privacy describes itself as a HIPAA-compliant Customer Data Platform (CDP) and privacy platform aimed at healthcare marketing teams. - The vendor states the product is designed to support performance marketing and analytics (for example, GA4, Google Ads, Meta, GTM) while attempting to prevent sensitive data/PHI from reaching non-compliant third-party tools by controlling, redacting, hashing, and routing event data. These are vendor-stated capabilities reflected in product documentation. - The product also extends beyond middleware CDP functionality into additional tooling commonly used in marketing stacks (consent management, tag management, session replay/heatmaps, A/B testing/personalization, embedded maps/videos, translations), with the stated objective of integrating multiple marketing tools within a healthcare-focused compliance posture.

Target market and market positioning

Target market: healthcare organizations and healthcare marketers running paid acquisition, analytics, and conversion measurement who face HIPAA and state privacy law risk.
Positioning: the vendor presents the product as a privacy-oriented solution for healthcare marketing. It is frequently compared to Freshpaint and is described by the vendor as enabling use of mainstream marketing destinations via server-side dispatch rather than direct third-party pixels.

Get a comprehensive analysis of Ours Privacy including market position, competitive landscape, adoption trends, and peer benchmarks.

Download full report →